BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33921468)

  • 21. Hemodialysis using a constant potassium gradient: rationale of a multicenter study.
    Redaelli B; Limido D; Beretta P; Viganò MR
    Int J Artif Organs; 1995 Nov; 18(11):731-4. PubMed ID: 8964637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic manifestations of hyperkalemia in hemodialysis patients.
    Nemati E; Taheri S
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):471-7. PubMed ID: 20427871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic changes during hemodiafiltration with different potassium removal rates.
    Severi S; Vecchietti S; Cavalcanti S; Mancini E; Santoro A
    Blood Purif; 2003; 21(6):381-8. PubMed ID: 14586180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).
    Wang F; Liu J; Hong L; Liang B; Graff C; Yang Y; Christiansen M; Olesen SP; Zhang L; Kanters JK
    Heart Rhythm; 2013 Oct; 10(10):1500-6. PubMed ID: 23872692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients.
    Yildiz A; Akkaya V; Sahin S; Tükek T; Besler M; Bozfakioglu S; Korkut F
    Perit Dial Int; 2001; 21(2):186-92. PubMed ID: 11330564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperkalaemia and haemodialysis patients: eletrocardiographic changes.
    Cobo Sánchez JL; Alconero Camarero AR; Casaus Pérez M; Maza Sota MA; Villa Llamazares C; Hiquera Roldán C; Menezo Viadero R; Alonso Nates R
    J Ren Care; 2007; 33(3):124-9. PubMed ID: 19160884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of index of cardiac-electrophysiological balance before and after hemodialysis in patients with end-stage renal disease.
    Sivri S; Çelik M
    J Electrocardiol; 2019; 54():72-75. PubMed ID: 30928820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can hemodialysis change QRS axis in patients without cardiovascular disease?
    Korkmaz A; Yıldız A; Kundi H; Başyigit F; Gürsoy HT; Uçar Elalmış Ö; Akyüz A; İleri M; Güray Ü
    Turk Kardiyol Dern Ars; 2018 Jun; 46(4):276-282. PubMed ID: 29853695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk of arrhythmias in hemodialysis patients vs healthy people].
    Milone F; Urso S; Garozzo M; Memeo AM; Volpe G; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S241-6. PubMed ID: 15750993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study.
    Muñoz RI; Montenegro J; Salcedo A; Gallardo I; Martínez I; Quintanilla N; Saracho R; Lekuona I
    Hemodial Int; 2008 Jan; 12(1):108-13. PubMed ID: 18271851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal averaged electrocardiography (SAECG) in patients on hemodialysis.
    Ichikawa H; Nagake Y; Makino H
    J Med; 1997; 28(3-4):229-43. PubMed ID: 9355027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hemodialysis: high risk patients for arrhythmias?
    Weber H; Schwarzer C; Stummvoll HK; Joskowics G; Wolf A; Steinbach K; Kaindl F
    Nephron; 1984; 37(3):180-5. PubMed ID: 6429558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive blood potassium measurement using signal-processed, single-lead ecg acquired from a handheld smartphone.
    Yasin OZ; Attia Z; Dillon JJ; DeSimone CV; Sapir Y; Dugan J; Somers VK; Ackerman MJ; Asirvatham SJ; Scott CG; Bennet KE; Ladewig DJ; Sadot D; Geva AB; Friedman PA
    J Electrocardiol; 2017; 50(5):620-625. PubMed ID: 28641860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease.
    Covic A; Diaconita M; Gusbeth-Tatomir P; Covic M; Botezan A; Ungureanu G; Goldsmith DJ
    Nephrol Dial Transplant; 2002 Dec; 17(12):2170-7. PubMed ID: 12454229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological response to dialysis: the role of dialysate potassium content and profiling.
    Santoro A; Mancini E; Gaggi R; Cavalcanti S; Severi S; Cagnoli L; Badiali F; Perrone B; London G; Fessy H; Mercadal L; Grandi F
    Contrib Nephrol; 2005; 149():295-305. PubMed ID: 15876853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease.
    Green D; Green HD; New DI; Kalra PA
    Nephrol Dial Transplant; 2013 Jan; 28(1):99-105. PubMed ID: 22610985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
    Krahn RE; Tulowitzki R; Gudleski GD; Murray B; Rajagopalan B; Su W; Muscarella M; Lambert J; Curtis AB; Panesar M
    Am J Nephrol; 2019; 49(1):74-80. PubMed ID: 30602157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the QT intervals, QT dispersion, and amplitude of T waves after hemodialysis.
    Drighil A; Madias JE; Benjelloun M; Kamoum H; Bennis A; Azzouzi L; Yazidi A; Ramdani B
    Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):137-44. PubMed ID: 17593182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmia recognition and classification using combined linear and nonlinear features of ECG signals.
    Elhaj FA; Salim N; Harris AR; Swee TT; Ahmed T
    Comput Methods Programs Biomed; 2016 Apr; 127():52-63. PubMed ID: 27000289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identify drug-induced T wave morphology changes by a cell-to-electrocardiogram model and validation with clinical trial data.
    Xue J; Gao W; Chen Y; Han X
    J Electrocardiol; 2009; 42(6):534-42. PubMed ID: 19700171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.